by William Newton in Texas Alkermes’ ALKS-3831 for schizophrenia and bipolar disorder has evoked mixed expert forecasts for how a Food and Drug Administration (FDA) Advisory Committee (AdCom) meeting on...
Foreseeing a global pandemic is not in any business leader’s job description. But perhaps the most vital skill for today’s…
Roche has reported that Evrysdi (risdiplam) lowered the mortality rate in infants aged two to seven months with symptomatic type 1 spinal muscular atrophy (SMA)…
The Manchester University NHS Foundation Trust (MFT) in the UK has said that the first patient in the OSCAR clinical trial received GlaxoSmithKline (GSK)’s investigational…
Johnson & Johnson (J&J) has reported positive interim data from an ongoing Phase I/IIa clinical trial of a potential Covid-19…
Marinus Pharmaceuticals is set to start patient enrolment in the Phase III RAISE clinical trial of ganaxolone for the treatment…
OncoImmune has reported that Saccovid reduced the risk of death and aided faster recovery in patients with severe or critical…
US-based biotechnology firm Novavax has started the first Phase III clinical trial of its potential Covid-19 vaccine, NVX-CoV2373, in the…
At the 56th annual European Association for the Study of Diabetes (EASD) 2020 meeting, positive results have been discussed for the novel oral hypoglycemic drug imeglimin, which is currently under…
Since early March, more than 500 companies have publicly announced disruptions to their planned and ongoing clinical trials due to the Covid-19 pandemic. Many companies have delayed the initiation of…
The CROWN study is a randomized, ongoing Phase III clinical trial that is comparing the efficacy of Pfizer’s Lorbrena/Lorviqua (lorlatinib) versus Pfizer’s Xalkori (crizotinib) in the first-line (1L) setting for…
EASD 2020: New Results from the EMPEROR-Reduced Trial Demonstrate the Efficacy of Empagliflozin in the Treatment of Heart Failure With or Without Type 2 Diabetes
At the 56th annual European Association for the Study of Diabetes (EASD) 2020 meeting, new results have been presented from the EMPEROR-Reduced trial, which demonstrated the efficacy of empagliflozin in…